Trastuzumab Injection: MedlinePlus Drug Information

trastuzumab  In the DESTINY-Breast04 trial, trastuzumab deruxtecan showed superior activity over standard chemotherapy options in patients with HER2-low advanced breast Trastuzumab prolongs survival in metastatic breast cancer patients whose tumors over express HER2 It is effective when given as a single agent or in

Trastuzumab belongs to class of monoclonal antibody It binds selectively to a protein called human epidermal growth factor receptor 2  Trastuzumab emtansine is a HER2-targeted, microtubule-stabilizing antibody-drug conjugate with about 3 chemotherapy molecules per antibody

(จากประโยชน์ของยา trastuzumab ทำให้การตรวจ HER2 ถือเป็นมาตรฐานของการตรวจชิ้นเนื้อมะเร็งเต้านมควบคู่กับก ารตรวจ hormone receptor โดยถือว่ามะเร็งเต้านมนั้นมี Cardiotoxicity Trastuzumab is a monoclonal antibody tyrosine kinase inhibitor that targets the HER2 receptor often over overexpressed or overactive in breast